We are live on
!
Find out more
BCM
Boxer Capital Management Portfolio holdings
AUM
$762M
1-Year Est. Return
1,125.36%
This Fund
S&P 500
This Quarter
Est. Return
-6.27%
1 Year Est. Return
+1,125.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
-$842M
(-72%)
Cap. Flow
-$767M
Cap. Flow
% of AUM
-230.79%
Top 10 Holdings %
Top 10 Hldgs %
72.35%
Holding
62
New
2
Increased
2
Reduced
10
Closed
34
Top Buys
| 1 |
Solid Biosciences
SLDB
|
+$5.31M |
| 2 |
Denali Therapeutics
DNLI
|
+$4.79M |
| 3 |
Prelude Therapeutics
PRLD
|
+$373K |
| 4 |
Kodiak Sciences
KOD
|
+$190K |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$124M |
| 2 |
Revolution Medicines
RVMD
|
+$120M |
| 3 |
Nuvalent
NUVL
|
+$52.4M |
| 4 |
MRUS
Merus
MRUS
|
+$52.3M |
| 5 |
Axsome Therapeutics
AXSM
|
+$39.8M |
Sector Composition
| 1 | Healthcare | 99.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$38.6B
| $46.6M | 14.02% |
1,317,977
-2,961,487
| -69% | -$120M |
|
|
2
Nuvalent
NUVL
| $31.9M | 9.6% |
450,000
-670,192
| -60% | -$52.4M |
|
|
MRUS
3
DELISTED
Merus
MRUS
| $29.5M | 8.86% |
700,000
-1,200,000
| -63% | -$52.3M |
|
|
RNAM
4
DELISTED
Avidity Biosciences
RNAM
| $25.5M | 7.68% |
865,000
-862,388
| -50% | -$26.9M |
|
5
AnaptysBio
ANAB
$1.65B
| $24.2M | 7.27% |
1,300,000
| – | – |
|
6
Xenon Pharmaceuticals
XENE
$6.52B
| $20.1M | 6.05% |
600,000
| – | – |
|
7
Replimune Group
REPL
$794M
| $17.5M | 5.27% |
1,796,341
| – | – |
|
|
APLS
8
DELISTED
Apellis Pharmaceuticals
APLS
| $15.6M | 4.69% |
713,000
-713,000
| -50% | -$19.7M |
|
|
CMRX
9
DELISTED
Chimerix, Inc.
CMRX
| $15.4M | 4.63% |
1,810,000
-250,000
| -12% | -$1.38M |
|
10
Tango Therapeutics
TNGX
$4.74B
| $14.2M | 4.28% |
10,380,999
| – | – |
|
11
Enliven Therapeutics
ELVN
$3.77B
| $13.2M | 3.97% |
671,358
| – | – |
|
12
Oric Pharmaceuticals
ORIC
$1.11B
| $9.67M | 2.91% |
1,732,571
| – | – |
|
|
DAWN
13
DELISTED
Day One Biopharmaceuticals
DAWN
| $9.44M | 2.84% |
1,189,943
| – | – |
|
14
Kymera Therapeutics
KYMR
$9.42B
| $8.9M | 2.68% |
325,000
-100,000
| -24% | -$3.65M |
|
15
Prothena Corp
PRTA
$432M
| $8.54M | 2.57% |
690,000
| – | – |
|
16
uniQure
QURE
$2.76B
| $7.95M | 2.39% |
750,000
| – | – |
|
17
Legend Biotech
LEGN
$4.48B
| $6.79M | 2.04% |
200,000
-500,000
| -71% | -$17.9M |
|
18
Nurix Therapeutics
NRIX
$2.44B
| $6.69M | 2.01% |
563,067
| – | – |
|
19
Amylyx Pharmaceuticals
AMLX
$1.96B
| $6.2M | 1.86% |
1,750,000
| – | – |
|
|
20
Solid Biosciences
SLDB
$901M
| $4.59M | 1.38% |
+1,240,700
| New | +$5.31M |
|
|
21
Denali Therapeutics
DNLI
$3.55B
| $3.4M | 1.02% |
+250,000
| New | +$4.79M |
|
|
22
Kodiak Sciences
KOD
$2.62B
| $2.91M | 0.87% |
1,035,000
+35,000
| +4% | +$190K |
|
|
23
Prelude Therapeutics
PRLD
$342M
| $1.62M | 0.49% |
2,108,014
+399,827
| +23% | +$373K |
|
24
Instil Bio
TIL
$51.7M
| $1.39M | 0.42% |
80,125
-275,375
| -77% | -$5.71M |
|
|
BOLD
25
Boundless Bio
BOLD
$55.3M
| $378K | 0.11% |
250,000
| – | – |
|
Similar funds
FTF
FPCP
CFS
PMWMG
SC
FCA
CCIP
GWM